REGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.83%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $110,626,649.96

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

^$982.29

▲ +14.31 (1.48%)

As of 05/17/2024 01:00 AM ET

Days: 30 | 90 | 365

Elon’s New Device is About to Shock the World

From InvestorPlace | Ad

Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”

Click here to see the details because there’s a lot of money at stake.

Regeneron Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/17/2024	Leonard S. Schleifer	CEO	Sell	22,830	$979.23	$22,355,820.90	466,877
5/14/2024	Leonard S. Schleifer	CEO	Sell	25,000	$979.25	$24,481,250.00	408,200
3/14/2024	Andrew J. Murphy	EVP	Sell	5,783	$956.47	$5,531,266.01	48,306
3/1/2024	Arthur F. Ryan	Director	Sell	100	$982.05	$98,205.00	18,282
3/1/2024	Marion Mccourt	EVP	Sell	358	$967.50	$346,365.00	13,431
2/26/2024	Bonnie L. Bassler	Director	Sell	854	$979.25	$836,279.50	1,382
2/22/2024	Joseph J. Larosa	EVP	Sell	1,000	$967.65	$967,650.00	37,543
2/7/2024	Joseph J. Larosa	EVP	Sell	1,000	$950.00	$950,000.00	38,543
2/5/2024	Marion Mccourt	EVP	Sell	1,000	$934.71	$934,710.00	13,789
2/1/2024	Arthur F. Ryan	Director	Sell	100	$954.22	$95,422.00	18,382
1/30/2024	Bonnie L. Bassler	Director	Sell	827	$959.00	$793,093.00	1,382
1/23/2024	Joseph L. Goldstein	Director	Sell	2,707	$950.00	$2,571,650.00	6,382
1/2/2024	George D. Yancopoulos	Insider	Sell	16,848	$900.00	$15,163,200.00	180,000
12/27/2023	Christopher R. Fenimore	SVP	Sell	2,448	$856.71	$2,097,226.08	14,372
12/27/2023	Michael S. Brown	Director	Sell	2,049	$898.00	$1,840,002.00	1,247
12/21/2023	Christopher R. Fenimore	SVP	Sell	1,680	$844.01	$1,417,936.80	17,070
12/1/2023	Arthur F. Ryan	Director	Sell	100	$817.30	$81,730.00	18,447
11/7/2023	Arthur F. Ryan	Director	Sell	100	$827.90	$82,790.00	18,547
11/1/2023	Marion Mccourt	EVP	Sell	1,000	$783.91	$783,910.00	19,803
10/13/2023	Huda Y. Zoghbi	Director	Sell	1,000	$850.00	$850,000.00	1,247
10/2/2023	Marion Mccourt	EVP	Sell	1,038	$827.00	$858,426.00	19,803
8/24/2023	Plew Daniel P Van	EVP	Sell	6,197	$841.71	$5,216,076.87	21,508
8/23/2023	Christine A. Poon	Director	Sell	12,280	$839.97	$10,314,831.60	2,037
8/23/2023	Robert E. Landry	CFO	Sell	223	$844.00	$188,212.00	31,699
8/22/2023	Neil Stahl	EVP	Sell	11,665	$840.98	$9,810,031.70	53,100
8/21/2023	Bonnie L. Bassler	Director	Sell	853	$829.00	$707,137.00	1,247
8/10/2023	Bonnie L. Bassler	Director	Sell	853	$789.00	$673,017.00	1,247
8/1/2023	Arthur F. Ryan	Director	Sell	100	$736.59	$73,659.00	18,647
7/3/2023	Arthur F. Ryan	Director	Sell	100	$716.88	$71,688.00	18,747
7/3/2023	Marion Mccourt	EVP	Sell	250	$710.09	$177,522.50	20,303
6/1/2023	Arthur F. Ryan	Director	Sell	100	$735.42	$73,542.00	18,847
6/1/2023	Marion Mccourt	EVP	Sell	250	$736.00	$184,000.00	20,553
4/21/2023	Michael S. Brown	Director	Sell	3,070	$798.42	$2,451,149.40	1,247
4/3/2023	Arthur F. Ryan	Director	Sell	100	$819.31	$81,931.00	19,047
4/3/2023	Marion Mccourt	EVP	Sell	1,100	$818.80	$900,680.00	20,803
3/27/2023	Robert E. Landry	CFO	Sell	183	$821.70	$150,371.10	32,929
3/24/2023	Bonnie L. Bassler	Director	Sell	1,240	$818.00	$1,014,320.00	1,247
3/23/2023	Christopher R. Fenimore	SVP	Sell	2,192	$806.47	$1,767,782.24	18,409
3/23/2023	George D. Yancopoulos	Insider	Sell	3,656	$804.26	$2,940,374.56	196,848
3/1/2023	Arthur F. Ryan	Director	Sell	100	$762.50	$76,250.00	19,147
3/1/2023	Marion Mccourt	EVP	Sell	1,100	$759.89	$835,879.00	20,803
2/7/2023	Marion Mccourt	EVP	Sell	1,000	$769.04	$769,040.00	22,079
2/6/2023	George D. Yancopoulos	Insider	Sell	13,189	$800.08	$10,552,255.12	200,504
2/6/2023	Joseph L. Goldstein	Director	Sell	3,613	$800.00	$2,890,400.00	6,247
2/6/2023	Robert E. Landry	CFO	Sell	752	$788.88	$593,237.76	32,105
2/3/2023	Bonnie L. Bassler	Director	Sell	1,021	$779.00	$795,359.00	1,247
2/3/2023	Robert E. Landry	CFO	Sell	739	$764.50	$564,965.50	32,105
1/27/2023	Michael S. Brown	Director	Sell	1	$747.00	$747.00	1,247
12/28/2022	N. Anthony Coles	Director	Sell	5,758	$714.11	$4,111,845.38	1,093
12/12/2022	Marion Mccourt	EVP	Sell	264	$730.17	$192,764.88	19,106
12/8/2022	Bonnie L. Bassler	Director	Sell	218	$779.00	$169,822.00	1,082
11/23/2022	Plew Daniel P Van	EVP	Sell	11,972	$740.75	$8,868,259.00	30,578
11/4/2022	Marion Mccourt	EVP	Sell	1,000	$727.82	$727,820.00	19,644
10/17/2022	Robert E. Landry	CFO	Sell	358	$739.50	$264,741.00	28,744
10/5/2022	Christopher R. Fenimore	SVP	Sell	1,844	$749.00	$1,381,156.00	16,425
10/3/2022	Christopher R. Fenimore	SVP	Sell	3,346	$724.00	$2,422,504.00	18,269
10/3/2022	Marc Tessier-Lavigne	Director	Sell	3,612	$718.00	$2,593,416.00	2,269
10/3/2022	Marion Mccourt	EVP	Sell	1,100	$705.39	$775,929.00	19,644
9/30/2022	Marc Tessier-Lavigne	Director	Sell	3,428	$698.00	$2,392,744.00	2,269
9/12/2022	Plew Daniel P Van	EVP	Sell	4,696	$716.38	$3,364,120.48	30,578
9/9/2022	Bonnie L. Bassler	Director	Sell	609	$741.00	$451,269.00	1,082
8/9/2022	Christine A. Poon	Director	Sell	15,000	$620.91	$9,313,650.00	1,872
8/5/2022	Neil Stahl	EVP	Sell	23,782	$612.61	$14,569,091.02	52,795
8/4/2022	Arthur F. Ryan	Director	Sell	10,453	$621.29	$6,494,344.37	18,408
8/1/2022	Marion Mccourt	EVP	Sell	1,100	$581.53	$639,683.00	19,644
7/1/2022	Marion Mccourt	EVP	Sell	1,100	$587.76	$646,536.00	19,644
5/2/2022	Arthur F. Ryan	Director	Sell	100	$650.78	$65,078.00	22,182
5/2/2022	Marion Mccourt	EVP	Sell	1,100	$656.97	$722,667.00	19,644
4/11/2022	Robert E. Landry	CFO	Sell	1,862	$734.06	$1,366,819.72	28,744
4/8/2022	Robert E. Landry	CFO	Sell	325	$737.79	$239,781.75	28,744
4/7/2022	Bonnie L. Bassler	Director	Sell	1,240	$725.00	$899,000.00	1,082
4/7/2022	Joseph J. Larosa	EVP	Sell	5,114	$721.10	$3,687,705.40	16,900
4/5/2022	Leonard S. Schleifer	CEO	Sell	4,461	$710.05	$3,167,533.05	465,922
4/1/2022	Arthur F. Ryan	Director	Sell	100	$692.81	$69,281.00	22,282
4/1/2022	Marion Mccourt	EVP	Sell	1,000	$701.82	$701,820.00	22,014
4/1/2022	Robert E. Landry	CFO	Sell	316	$695.81	$219,875.96
3/31/2022	Leonard S. Schleifer	CEO	Sell	2,886	$710.01	$2,049,088.86	465,922
3/30/2022	Michael S. Brown	Director	Sell	408	$699.00	$285,192.00
3/29/2022	Robert E. Landry	CFO	Sell	2,683	$687.90	$1,845,635.70
3/21/2022	Marc Tessier-Lavigne	Director	Sell	7,439	$690.00	$5,132,910.00
3/21/2022	Robert E. Landry	CFO	Sell	300	$693.00	$207,900.00
3/17/2022	Robert E. Landry	CFO	Sell	83	$686.00	$56,938.00
3/16/2022	Marc Tessier-Lavigne	Director	Sell	4,361	$675.00	$2,943,675.00
2/28/2022	George L. Sing	Director	Sell	2,000	$615.50	$1,231,000.00
2/25/2022	George L. Sing	Director	Sell	2,000	$621.00	$1,242,000.00
2/23/2022	Plew Daniel P Van	EVP	Sell	6,781	$613.99	$4,163,466.19
2/1/2022	Arthur F. Ryan	Director	Sell	100	$607.14	$60,714.00
2/1/2022	Marion Mccourt	EVP	Sell	1,000	$607.46	$607,460.00
12/13/2021	Marion Mccourt	EVP	Sell	344	$653.12	$224,673.28
12/13/2021	Robert E. Landry	CFO	Sell	116	$662.50	$76,850.00
12/10/2021	Andrew J. Murphy	EVP	Sell	7,122	$666.27	$4,745,174.94
12/10/2021	Robert E. Landry	CFO	Sell	781	$666.42	$520,474.02
12/9/2021	Marc Tessier-Lavigne	Director	Sell	3,784	$665.00	$2,516,360.00
12/1/2021	Arthur F. Ryan	Director	Sell	100	$637.53	$63,753.00
12/1/2021	Marion Mccourt	EVP	Sell	1,000	$639.13	$639,130.00
11/22/2021	George L. Sing	Director	Sell	2,000	$657.50	$1,315,000.00
11/18/2021	George L. Sing	Director	Sell	4,000	$650.00	$2,600,000.00
11/17/2021	Robert E. Landry	CFO	Sell	681	$645.08	$439,299.48
11/16/2021	Andrew J. Murphy	EVP	Sell	7,167	$647.17	$4,638,267.39
11/16/2021	George L. Sing	Director	Sell	6,000	$656.26	$3,937,560.00
10/1/2021	Arthur F. Ryan	Director	Sell	100	$569.49	$56,949.00
10/1/2021	Marion Mccourt	EVP	Sell	1,000	$576.75	$576,750.00
9/15/2021	N. Anthony Coles	Director	Sell	11,948	$658.98	$7,873,493.04	7,811
9/13/2021	Michael S. Brown	Director	Sell	9,704	$648.16	$6,289,744.64	6,328
9/10/2021	Joseph L. Goldstein	Director	Sell	2,479	$650.00	$1,611,350.00	8,370
8/30/2021	George L. Sing	Director	Sell	1,000	$672.50	$672,500.00
8/26/2021	George L. Sing	Director	Sell	150	$672.00	$100,800.00	43,358
8/23/2021	Joseph J. Larosa	EVP	Sell	3,425	$661.84	$2,266,802.00	23,182
8/18/2021	Leonard S. Schleifer	CEO	Sell	200,000	$650.03	$130,006,000.00
8/18/2021	P. Roy Vagelos	Director	Sell	10,039	$650.04	$6,525,751.56
8/13/2021	George L. Sing	Director	Sell	500	$620.00	$310,000.00	47,063
8/11/2021	George L. Sing	Director	Sell	2,000	$620.50	$1,241,000.00	47,063
8/10/2021	Daniel P. Van Plew	EVP	Sell	6,603	$611.86	$4,040,111.58	51,931
8/9/2021	Michael S. Brown	Director	Sell	1,687	$612.38	$1,033,085.06
8/9/2021	Robert E. Landry	CFO	Sell	364	$617.83	$224,890.12
8/5/2021	Bonnie L. Bassler	Director	Sell	2,559	$600.00	$1,535,400.00	3,450
8/5/2021	George D. Yancopoulos	Insider	Sell	50,000	$600.06	$30,003,000.00	937,483
8/2/2021	Marion Mccourt	EVP	Sell	1,000	$577.12	$577,120.00	18,038
7/6/2021	Joseph J. Larosa	EVP	Sell	3,398	$580.00	$1,970,840.00	23,182
7/1/2021	Arthur F. Ryan	Director	Sell	100	$564.50	$56,450.00	23,589
6/25/2021	Michael S. Brown	Director	Sell	2,084	$549.00	$1,144,116.00	2,975
6/21/2021	George D. Yancopoulos	Insider	Sell	80,000	$538.90	$43,112,000.00	987,483
6/14/2021	Arthur F. Ryan	Director	Sell	100	$524.76	$52,476.00	23,673

Elon’s New Device is About to Shock the World

From InvestorPlace | Ad

Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”

Click here to see the details because there’s a lot of money at stake.

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

83.31% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/17/2024	Citizens Financial Group Inc. RI	12,003	$11.55M	0.4%	-2.3%	0.011%
5/17/2024	Plato Investment Management Ltd	2,394	$2.30M	0.2%	+1,846.3%	0.002%
5/17/2024	XML Financial LLC	1,237	$1.19M	0.1%	-1.6%	0.001%
5/17/2024	iA Global Asset Management Inc.	14,619	$14.07M	0.2%	+32.5%	0.013%
5/17/2024	Jaffetilchin Investment Partners LLC	247	$0.24M	0.0%	-7.1%	0.000%
5/17/2024	Comerica Bank	15,306	$14.73M	0.1%	-2.3%	0.014%
5/17/2024	Hancock Whitney Corp	7,879	$7.58M	0.3%	+3.7%	0.007%
5/17/2024	Tidal Investments LLC	4,955	$4.77M	0.1%	+16.8%	0.004%
5/16/2024	California State Teachers Retirement System	173,049	$166.56M	0.2%	+1.0%	0.157%
5/16/2024	Meiji Yasuda Life Insurance Co	3,501	$3.37M	0.1%	+17.6%	0.003%
5/16/2024	B. Riley Wealth Advisors Inc.	1,006	$0.97M	0.0%	-13.6%	0.001%
5/16/2024	Janus Henderson Group PLC	103,992	$100.09M	0.1%	-7.8%	0.094%
5/16/2024	Kennedy Capital Management LLC	5,413	$5.21M	0.1%	N/A	0.005%
5/16/2024	Zurich Insurance Group Ltd FI	52,968	$50.98M	0.5%	+64.3%	0.048%
5/16/2024	Ashford Capital Management Inc.	1,572	$1.51M	0.2%	-3.6%	0.001%
5/15/2024	Ascent Group LLC	505	$0.49M	0.0%	-30.6%	0.000%
5/15/2024	SVB Wealth LLC	1,056	$1.02M	0.0%	-5.5%	0.001%
5/15/2024	Evergreen Wealth Solutions LLC	613	$0.59M	0.4%	-7.5%	0.001%
5/15/2024	Public Employees Retirement System of Ohio	63,970	$61.57M	0.2%	-3.7%	0.058%
5/15/2024	Public Employees Retirement Association of Colorado	15,353	$14.78M	0.1%	-4.5%	0.014%
5/15/2024	Morse Asset Management Inc	4,584	$4.41M	1.1%	+1.0%	0.004%
5/15/2024	Bellevue Group AG	7,077	$6.81M	0.1%	-33.9%	0.006%
5/15/2024	Kentucky Retirement Systems Insurance Trust Fund	3,486	$3.36M	0.2%	-8.7%	0.003%
5/15/2024	Kentucky Retirement Systems	8,023	$7.72M	0.2%	-6.4%	0.007%
5/15/2024	Price T Rowe Associates Inc. MD	902,613	$868.76M	0.1%	+25.7%	0.819%
5/15/2024	BOKF NA	1,845	$1.79M	0.0%	-1.6%	0.002%
5/15/2024	Magnetar Financial LLC	33,257	$32.01M	0.7%	N/A	0.030%
5/15/2024	Lazard Asset Management LLC	16,309	$15.70M	0.0%	+52.7%	0.015%
5/15/2024	Epoch Investment Partners Inc.	103,551	$99.67M	0.4%	N/A	0.094%
5/15/2024	LRI Investments LLC	226	$0.22M	0.0%	N/A	0.000%
5/15/2024	1832 Asset Management L.P.	2,806	$2.70M	0.0%	+24.5%	0.003%
5/15/2024	Gabelli Funds LLC	1,859	$1.79M	0.0%	+3.0%	0.002%
5/15/2024	Gamco Investors INC. ET AL	239	$0.23M	0.0%	N/A	0.000%
5/14/2024	Canada Pension Plan Investment Board	125,290	$120.59M	0.1%	-1.3%	0.114%
5/14/2024	Westwood Holdings Group Inc.	12,503	$12.03M	0.1%	-2.1%	0.011%
5/14/2024	JT Stratford LLC	1,965	$1.89M	0.4%	+32.0%	0.002%
5/14/2024	Capital World Investors	4,654,855	$4.48B	0.7%	-9.3%	4.224%
5/14/2024	Capital Research Global Investors	394,182	$379.40M	0.1%	-3.0%	0.358%
5/14/2024	Capital International Sarl	40,418	$38.90M	1.3%	+29.8%	0.037%
5/14/2024	Toronto Dominion Bank	62,220	$59.89M	0.1%	+1.0%	0.056%
5/14/2024	Capital International Ltd. CA	31,033	$29.87M	1.4%	+29.2%	0.028%
5/14/2024	Capital International Inc. CA	56,369	$54.26M	0.7%	+5.2%	0.051%
5/14/2024	Capital International Investors	3,129,010	$3.01B	0.6%	+7.3%	2.840%
5/14/2024	Capital Group Private Client Services Inc.	103,869	$99.97M	1.0%	+11.7%	0.094%
5/14/2024	Capital Group Investment Management PTE. LTD.	8,139	$7.83M	1.4%	-40.1%	0.007%
5/14/2024	Advisors Asset Management Inc.	7,617	$7.33M	0.1%	-9.0%	0.007%
5/14/2024	EP Wealth Advisors LLC	1,275	$1.23M	0.0%	+9.7%	0.001%
5/14/2024	Freestone Capital Holdings LLC	592	$0.57M	0.0%	N/A	0.001%
5/14/2024	CreativeOne Wealth LLC	208	$0.20M	0.0%	N/A	0.000%
5/14/2024	Vident Advisory LLC	24,732	$23.81M	0.5%	+24.5%	0.022%
5/14/2024	Sculati Wealth Management LLC	2,047	$1.97M	0.8%	+0.7%	0.002%
5/14/2024	Fayez Sarofim & Co	2,675	$2.58M	0.0%	-2.7%	0.002%
5/14/2024	Shell Asset Management Co.	14,076	$13.55M	0.6%	-0.7%	0.013%
5/14/2024	Crewe Advisors LLC	29	$28K	0.0%	N/A	0.000%
5/14/2024	Ossiam	5,429	$5.23M	0.1%	+5.9%	0.005%
5/14/2024	Natixis	5,456	$5.25M	0.0%	-75.2%	0.005%
5/14/2024	Pitcairn Co.	838	$0.81M	0.1%	+6.5%	0.001%
5/14/2024	Healthcare of Ontario Pension Plan Trust Fund	12,000	$11.55M	0.0%	-29.1%	0.011%
5/14/2024	CANADA LIFE ASSURANCE Co	101,164	$97.45M	0.2%	-9.7%	0.092%
5/14/2024	American International Group Inc.	38,658	$37.21M	0.1%	-2.0%	0.035%
5/14/2024	Twin Capital Management Inc.	3,787	$3.65M	0.5%	-5.3%	0.003%
5/14/2024	Lake Street Advisors Group LLC	746	$0.72M	0.0%	+41.3%	0.001%
5/14/2024	Arjuna Capital	279	$0.27M	0.1%	+6.9%	0.000%
5/13/2024	Bessemer Group Inc.	5,075	$4.89M	0.0%	+107.1%	0.005%
5/13/2024	Capitolis Liquid Global Markets LLC	38,000	$36.58M	0.6%	N/A	0.035%
5/13/2024	UniSuper Management Pty Ltd	2,409	$2.32M	0.0%	+174.1%	0.002%
5/13/2024	O Shaughnessy Asset Management LLC	6,920	$6.66M	0.1%	+17.5%	0.006%
5/13/2024	Ameritas Investment Partners Inc.	4,272	$4.11M	0.1%	-0.6%	0.004%
5/11/2024	Covestor Ltd	202	$0.20M	0.1%	+7.4%	0.000%
5/11/2024	Beaumont Financial Advisors LLC	292	$0.28M	0.0%	-13.4%	0.000%
5/11/2024	Jacobi Capital Management LLC	1,139	$1.10M	0.1%	+1.8%	0.001%
5/11/2024	Edgestream Partners L.P.	7,639	$7.35M	0.4%	N/A	0.007%
5/11/2024	Cercano Management LLC	38,393	$36.95M	1.0%	N/A	0.035%
5/10/2024	Ontario Teachers Pension Plan Board	2,434	$2.34M	0.0%	-18.1%	0.002%
5/10/2024	Acadian Asset Management LLC	62,141	$59.79M	0.2%	+37.2%	0.057%
5/10/2024	Fiducient Advisors LLC	313	$0.30M	0.1%	N/A	0.000%
5/10/2024	TIAA Trust National Association	2,267	$2.18M	0.0%	-3.4%	0.002%
5/10/2024	Vanguard Group Inc.	8,930,241	$8.60B	0.2%	+1.0%	8.136%
5/10/2024	Intech Investment Management LLC	12,898	$12.41M	0.2%	-30.6%	0.012%
5/10/2024	Mitsubishi UFJ Trust & Banking Corp	85,793	$82.58M	0.2%	-4.1%	0.078%
5/10/2024	First Foundation Advisors	3,109	$2.99M	0.1%	+1.6%	0.003%
5/10/2024	Banco Santander S.A.	7,445	$7.17M	0.1%	-11.4%	0.007%
5/9/2024	Great Lakes Retirement Inc.	2,139	$2.06M	0.3%	N/A	0.002%
5/9/2024	Dorsey & Whitney Trust CO LLC	587	$0.57M	0.0%	+26.8%	0.001%
5/9/2024	Orion Portfolio Solutions LLC	2,735	$2.63M	0.0%	-1.3%	0.002%
5/9/2024	Lord Abbett & CO. LLC	46,282	$44.55M	0.1%	N/A	0.042%
5/9/2024	Beacon Investment Advisory Services Inc.	26,396	$25.41M	1.1%	+1.6%	0.024%
5/9/2024	Ledyard National Bank	6,981	$6.72M	0.7%	-6.1%	0.006%
5/9/2024	Mitsubishi UFJ Asset Management Co. Ltd.	132,864	$127.88M	0.2%	+19.3%	0.121%
5/9/2024	Fortis Capital Advisors LLC	1,050	$1.01M	0.4%	+219.1%	0.001%
5/9/2024	Angeles Wealth Management LLC	325	$0.31M	0.0%	+3.5%	0.000%
5/9/2024	State Board of Administration of Florida Retirement System	124,124	$119.47M	0.2%	+5.5%	0.113%
5/9/2024	TD Asset Management Inc	269,511	$259.40M	0.2%	+162.9%	0.246%
5/9/2024	WP Advisors LLC	2,776	$2.67M	0.9%	-1.4%	0.003%
5/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	404,008	$388.85M	1.0%	+4.9%	0.368%
5/8/2024	Camarda Financial Advisors LLC	1,084	$1.04M	0.4%	N/A	0.001%
5/8/2024	Taurus Asset Management LLC	15,907	$15.31M	1.6%	-0.9%	0.014%
5/8/2024	Cozad Asset Management Inc.	3,421	$3.29M	0.3%	-6.0%	0.003%
5/8/2024	Sheets Smith Wealth Management	1,058	$1.02M	0.1%	+131.5%	0.001%
5/8/2024	Bleakley Financial Group LLC	14,380	$13.84M	0.4%	+60.2%	0.013%

Data available starting January 2016

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Today's Range

Now: $982.29

$966.00

$982.77

50 Day Range

MA: $942.68

$883.20

$984.64

52 Week Range

Now: $982.29

$684.80

$998.33

Volume

386,559 shs

Average Volume

461,908 shs

Market Capitalization

$108.23 billion

P/E Ratio

29.02

Dividend Yield

N/A

Beta

0.17

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top insider investors include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Joseph L Goldstein (Director)
Marc Tessier-Lavigne (Director)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Huda Y Zoghbi (Director)
Michael S Brown (Director)
N Anthony Coles (Director)
Learn More about top insider investors at Regeneron Pharmaceuticals.
Who are the major institutional investors of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 8.14%
Capital World Investors — 4.22%
Capital International Investors — 2.84%
Price T Rowe Associates Inc. MD — 0.82%
Bank of New York Mellon Corp — 0.81%
BNP PARIBAS ASSET MANAGEMENT Holding S.A. — 0.37%
Learn More about top institutional investors of Regeneron Pharmaceuticals stock.
Which institutional investors are selling Regeneron Pharmaceuticals stock?: In the previous quarter, REGN stock was sold by these institutional investors:
Capital World Investors
Bank of New York Mellon Corp
Jane Street Group LLC
JPMorgan Chase & Co.
Assenagon Asset Management S.A.
PEAK6 Investments LLC
Natixis
Walleye Trading LLC
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Joseph L Goldstein (Director)
Marc Tessier-Lavigne (Director)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Huda Y Zoghbi (Director)
Learn More investors selling Regeneron Pharmaceuticals stock.
Which institutional investors are buying Regeneron Pharmaceuticals stock?: During the last quarter, REGN stock was purchased by institutional investors including:
Global Assets Advisory LLC
Capital International Investors
Price T Rowe Associates Inc. MD
TD Asset Management Inc
Epoch Investment Partners Inc.
Vanguard Group Inc.
Lord Abbett & CO. LLC
Cercano Management LLC